The lymphoid lineage-specific actin-uncapping protein Rltpr is essential for costimulation via CD28 and the development of regulatory T cells

Nature Immunology

Volumn 14, Issue 8, 2013, Pages 858-866

  Liang, Yinming ^a,b,c   Cucchetti, Margot ^a,b,c   Roncagalli, Romain ^a,b,c   Yokosuka, Tadashi ^d,e   Malzac, Aurélie ^a,b,c   Bertosio, Elodie ^a,b,c   Imbert, Jean ^b,f   Nijman, Isaac J ^g   Suchanek, Miloslav ^h   Saito, Takashi ^d,i   Wülfing, Christoph ^j   Malissen, Bernard ^a,b,c   Malissen, Marie ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS   (France)

^d RIKEN Center for Integrative Medical Sciences   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f Aix Marseille university   (France)

^g HUBRECHT INSTITUTE   (Netherlands)

^h Osaka University ^*  (Czech Republic)

ⁱ OSAKA UNIVERSITY   (Japan)

^j UNIVERSITY OF BRISTOL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN CAPPING PROTEIN; ADAPTOR PROTEIN; B7 ANTIGEN; CARMA1 PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; CD28 ANTIGEN; ETHYLNITROSOUREA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUTANT PROTEIN; PROTEIN KINASE B; PROTEIN KINASE C THETA; RLTPR PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; IMMUNOLOGICAL SYNAPSE; IMMUNOSTIMULATION; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD28; BASE SEQUENCE; CARD SIGNALING ADAPTOR PROTEINS; CARRIER PROTEINS; FLOW CYTOMETRY; GUANYLATE CYCLASE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN KINASE C; RECEPTORS, ANTIGEN, T-CELL; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, REGULATORY;

EID: 84880830434     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2634     Document Type: Article

References (58)

1. Okkenhaug, K. et al. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat. Immunol. 2, 325-332 (2001).
2. Holdorf, A.D., Lee, K.H., Burack, W.R., Allen, P.M. & Shaw, A.S. Regulation of Lck activity by CD4 and CD28 in the immunological synapse. Nat. Immunol. 3, 259-264 (2002).
3. Kong, K.F. et al. A motif in the V3 domain of the kinase PKC-? determines its localization in the immunological synapse and functions in T cells via association with CD28. Nat. Immunol. 12, 1105-1112 (2011).
4. Raab, M., Pfister, S. & Rudd, C.E. CD28 signaling via VAV/SLP-76 adaptors: Regulation of cytokine transcription independent of TCR ligation. Immunity 15, 921-933 (2001).
5. 4+ T cell clonal expansion during infection independently of its YMNM and PYAP motifs. J. Immunol. 189, 2909-2917 (2012).
6. Thome, M., Charton, J.E., Pelzer, C. & Hailfinger, S. Antigen receptor signaling to NF-κB via CARMA1, BCL10, and MALT1. Cold Spring Harb. Perspect. Biol. 2, a003004 (2010).
7. Wang, X., Chuang, H.C., Li, J.P. & Tan, T.H. Regulation of PKC-? function by phosphorylation in T cell receptor signaling. Front. Immunol. 3, 197 (2012).
8. Jiang, C. & Lin, X. Regulation of NF-κB by the CARD proteins. Immunol. Rev. 246, 141-153 (2012).
9. Yokosuka, T. et al. Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C ? translocation. Immunity 29, 589-601 (2008).
10. Dustin, M.L. The cellular context of T cell signaling. Immunity 30, 482-492 (2009).
11. Vardhana, S., Choudhuri, K., Varma, R. & Dustin, M.L. Essential role of ubiquitin and TSG101 protein in formation and function of the central supramolecular activation cluster. Immunity 32, 531-540 (2010).
12. Aguado, E. et al. Induction of T helper type 2 immunity by a point mutation in the LAT adaptor. Science 296, 2036-2040 (2002).
13. Sommers, C.L. et al. A LAT mutation that inhibits T cell development yet induces lymphoproliferation. Science 296, 2040-2043 (2002).
14. Wang, Y. et al. Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cells. J. Immunol. 180, 1565-1575 (2008).
15. Mingueneau, M. et al. Loss of the LAT adaptor converts antigen-responsive T cells into pathogenic effectors that function independently of the T cell receptor. Immunity 31, 197-208 (2009).
16. 4+ T Cells. Front. Immunol. 3, 1-14 (2012).
17. Beutler, B. et al. Genetic analysis of resistance to viral infection. Nat. Rev. Immunol. 7, 753-766 (2007).
18. Cook, M.C., Vinuesa, C.G. & Goodnow, C.C. ENU-mutagenesis: Insight into immune function and pathology. Curr. Opin. Immunol. 18, 627-633 (2006).
19. Liang, Y., Niederstrasser, H., Edwards, M., Jackson, C.E. & Cooper, J.A. Distinct roles for CARMIL isoforms in cell migration. Mol. Biol. Cell 20, 5290-5305 (2009).
20. Hernandez-Valladares, M. et al. Structural characterization of a capping protein interaction motif defines a family of actin filament regulators. Nat. Struct. Mol. Biol. 17, 497-503 (2010).
21. Fujiwara, I., Remmert, K. & Hammer, J.A. III. Direct observation of the uncapping of capping protein-capped actin filaments by CARMIL homology domain 3. J. Biol. Chem. 285, 2707-2720 (2010).
22. Yang, C. et al. Mammalian CARMIL inhibits actin filament capping by capping protein. Dev. Cell 9, 209-221 (2005).
23. Ng, A.C. et al. Human leucine-rich repeat proteins: A genome-wide bioinformatic categorization and functional analysis in innate immunity. Proc. Natl. Acad. Sci. USA 108 (SUPPL. 1), 4631-4638 (2011).
24. Junttila, M.R., Saarinen, S., Schmidt, T., Kast, J. & Westermarck, J. Single-step Strep-tag purification for the isolation and identification of protein complexes from mammalian cells. Proteomics 5, 1199-1203 (2005).
25. Bachmann, M.F. et al. T cell responses are governed by avidity and co-stimulatory thresholds. Eur. J. Immunol. 26, 2017-2022 (1996).
26. Shahinian, A. et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261, 609-612 (1993).
27. Hogquist, K.A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17-27 (1994).
28. 4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 341, 746-749 (1989).
29. Tai, X., Cowan, M., Feigenbaum, L. & Singer, A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6, 152-162 (2005).
30. Román, E., Shino, H., Qin, F.X. & Liu, Y.J. Cutting edge: Hematopoietic-derived APCs select regulatory T cells in thymus. J. Immunol. 185, 3819-3823 (2010).
31. Vang, K.B. et al. Cutting edge: CD28 and c-Rel-dependent pathways initiate regulatory T cell development. J. Immunol. 184, 4074-4077 (2010).
32. Nguyen, A.W. & Daugherty, P.S. Evolutionary optimization of fluorescent proteins for intracellular FRET. Nat. Biotechnol. 23, 355-360 (2005).
33. Campi, G., Varma, R. & Dustin, M.L. Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J. Exp. Med. 202, 1031-1036 (2005).
34. Yokosuka, T. et al. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat. Immunol. 6, 1253-1262 (2005).
35. Yokosuka, T. et al. Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation. Immunity 33, 326-339 (2010).
36. Zanin-Zhorov, A. et al. Protein kinase C-? mediates negative feedback on regulatory T cell function. Science 328, 372-376 (2010).
37. Singleton, K.L. et al. Spatiotemporal patterning during T cell activation is highly diverse. Sci. Signal. 2, ra15 (2009).
38. Singleton, K. et al. A large T cell invagination with CD2 enrichment resets receptor engagement in the immunological synapse. J. Immunol. 177, 4402-4413 (2006).
39. DeFord-Watts, L.M. et al. The CD3 ? subunit contains a phosphoinositide-binding motif that is required for the stable accumulation of TCR-CD3 complex at the immunological synapse. J. Immunol. 186, 6839-6847 (2011).
40. Cáfaï, D. et al. CD28 receptor endocytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and costimulation. J. Immunol. 160, 2223-2230 (1998).
41. Badour, K. et al. Interaction of the Wiskott-Aldrich syndrome protein with sorting nexin 9 is required for CD28 endocytosis and cosignaling in T cells. Proc. Natl. Acad. Sci. USA 104, 1593-1598 (2007).
42. Barnes, M.J. et al. Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol. 7, e51 (2009).
43. Molinero, L.L. et al. CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells. J. Immunol. 182, 6736-6743 (2009).
44. Jung, G., Remmert, K., Wu, X., Volosky, J.M. & Hammer, J.A. III. The Dictyostelium CARMIL protein links capping protein and the Arp2/3 complex to type I myosins through their SH3 domains. J. Cell Biol. 153, 1479-1497 (2001).
45. Takeda, S. et al. Actin capping protein and its inhibitor CARMIL: How intrinsically disordered regions function. Phys. Biol. 8, 035005 (2011).
46. Burkhardt, J.K., Carrizosa, E. & Shaffer, M.H. The actin cytoskeleton in T cell activation. Annu. Rev. Immunol. 26, 233-259 (2008).
47. Hutchings, N.J., Clarkson, N., Chalkley, R., Barclay, A.N. & Brown, M.H. Linking the T cell surface protein CD2 to the actin-capping protein CAPZ via CMS and CIN85. J. Biol. Chem. 278, 22396-22403 (2003).
48. Matsuzaka, Y. et al. Identification, expression analysis and polymorphism of a novel RLTPR gene encoding a RGD motif, tropomodulin domain and proline/leucine-rich regions. Gene 343, 291-304 (2004).
49. Pointon, J.J. et al. The chromosome 16q region associated with ankylosing spondylitis includes the candidate gene tumour necrosis factor receptor type 1-associated death domain (TRADD). Ann. Rheum. Dis. 69, 1243-1246 (2010).
50. 4+ T cells from T cell receptor transgenic mice. J. Exp. Med. 176, 1091-1098 (1992).
51. Malissen, M. et al. Altered T cell development in mice with a targeted mutation of the CD3-e gene. EMBO J. 14, 4641-4653 (1995).
52. Ordoñez-Rueda, D. et al. A hypomorphic mutation in the Gfi1 transcriptional repressor results in a novel form of neutropenia. Eur. J. Immunol. 42, 2395-2408 (2012).
53. Harakalova, M. et al. Multiplexed array-based and in-solution genomic enrichment for flexible and cost-effective targeted next-generation sequencing. Nat. Protoc. 6, 1870-1886 (2011).
54. Kitamura, T. et al. Retrovirus-mediated gene transfer and expression cloning: Powerful tools in functional genomics. Exp. Hematol. 31, 1007-1014 (2003).
55. Heavey, B., Charalambous, C., Cobaleda, C. & Busslinger, M. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors. EMBO J. 22, 3887-3897 (2003).
56. Morita, S., Kojima, T. & Kitamura, T. Plat-E: An efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063-1066 (2000).
57. Reske-Kunz, A.B. & Rude, E. Insulin-specific T cell hybridomas derived from (H-2b x H-2k)F1 mice preferably employ F1-unique restriction elements for antigen recognition. Eur. J. Immunol. 15, 1048-1054 (1985).
58. Tokunaga, M., Kitamura, K., Saito, K., Iwane, A.H. & Yanagida, T. Single molecule imaging of fluorophores and enzymatic reactions achieved by objective-type total internal reflection fluorescence microscopy. Biochem. Biophys. Res. Commun. 235, 47-53 (1997). Japan Science and Technology Agency